Simulations Plus
Engineering Software · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Research Triangle Park PO Box 12317, Dur...Phone Number
(661) 723-7723Website
www.simulations-plus.comRevenue
$80.5 MillionStock Symbol
SLPIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
5
3
5
2
2
About Simulations Plus
Simulations Plus is a software and consulting company that specializes in providing modeling and simulation solutions for the pharmaceutical and biotechnology industries. The company develops advanced software tools that help drug developers predict how medications will behave in the human body, enabling more efficient drug discovery and development processes. Their solutions support various aspects of pharmaceutical research, including absorption, distribution, metabolism, and excretion modeling, as well as population pharmacokinetics and clinical trial simulations. Simulations Plus serves a global client base of pharmaceutical companies, biotechnology firms, academic institutions, and regulatory agencies, helping them make more informed decisions throughout the drug development lifecycle. The company is recognized for its innovative approach to computational modeling and its commitment to advancing pharmaceutical science through technology.If you need current, specific information abRead more
Simulations Plus Org Chart
NM
Senior Director, Business Operations
AP
Senior Director, Business Development
KH
Inside Sales Director
AM
Director, Business Development
HS
Director, Business Development
JH
Director, Business
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Simulations Plus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Simulations Plus
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Simulations Plus has new funding data
Product Launch: Get notified when Simulations Plus launches new products
Simulations Plus, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Simulations Plus is spiking on competitors!
Check if Simulations Plus has recently received funding, and reach out quickly before it becomes old news!
Click to see if Simulations Plus had a recent Job posting/layoffs
Earning: See what the market has to say on Simulations Plus recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Simulations Plus as Masked Content
Find more new buyers
Compare Similar Companies to Simulations Plus
Compare insights from companies similar to Simulations Plus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Simulations Plus
$80.5M
201-500
Public
$5.8M
1996
JoAnne SchaberickFounder & CEO & Chief Awesomeness Officer
Company Profile Activity
Activity Insights
Simulations Plus is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Simulations Plus is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Simulations Plus.
Simulations Plus financials insights
Gather financial insights about Simulations Plus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$5.8M
Simulations Plus Tech Stack
A closer look at the technologies used by Simulations Plus
See more technologies
Most Recent Scoops
Open Position
Open Position
Person-Based
Events
Open Position
Person-Based
Bioengineering, Pharmaceuticals, Artificial Intelligence
Simulations Plus News & Media
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
BALA CYNWYD, Pa., June 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.Shareholder Alert: Ademi LLP investigates whether Simulations Plus, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, June 16, 2026 /PRNewswire/ -- Ademi LLP is investigating Simulations Plus (NASDAQ: SLP) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Altaris. Click here to learn how to join our investigation and obtain...Robbins LLP Reminds SLP Stockholders of its Investigation into Simulation Plus, Inc.; Contact the Firm for Information
Robbins LLP Reminds SLP Stockholders of its Investigation into Simulation Plus, Inc.; Contact the Firm for InformationSimulation Plus, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws
Simulation Plus, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws
Read more news
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Simulations Plus
Sign Up For FreeTo access detailed company insights
Simulations Plus is a software and consulting company that specializes in providing modeling and simulation solutions for the pharmaceutical and biotechnology industries. The company develops advanced software tools that help drug developers predict how medications will behave in the human body, enabling more efficient drug discovery and developmen... Read More
